276 related articles for article (PubMed ID: 23240057)
1. MiR-27 as a prognostic marker for breast cancer progression and patient survival.
Tang W; Zhu J; Su S; Wu W; Liu Q; Su F; Yu F
PLoS One; 2012; 7(12):e51702. PubMed ID: 23240057
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
[TBL] [Abstract][Full Text] [Related]
3. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
[TBL] [Abstract][Full Text] [Related]
4. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.
Li X; Mertens-Talcott SU; Zhang S; Kim K; Ball J; Safe S
Endocrinology; 2010 Jun; 151(6):2462-73. PubMed ID: 20382698
[TBL] [Abstract][Full Text] [Related]
6. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
[TBL] [Abstract][Full Text] [Related]
7. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis.
Noratto GD; Jutooru I; Safe S; Angel-Morales G; Mertens-Talcott SU
Mol Nutr Food Res; 2013 Sep; 57(9):1638-48. PubMed ID: 23471840
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
Dong LL; Chen LM; Wang WM; Zhang LM
Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
[TBL] [Abstract][Full Text] [Related]
9. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S
Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival.
Li Y; Hong F; Yu Z
J Int Med Res; 2013 Jun; 41(3):596-602. PubMed ID: 23696595
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of miR-195 with invasiveness and prognosis of breast cancer].
Song CG; Wu XY; Wang C; Fu FM; Shao ZM
Zhonghua Wai Ke Za Zhi; 2012 Apr; 50(4):353-6. PubMed ID: 22800791
[TBL] [Abstract][Full Text] [Related]
12. In situ hybridization analysis of the expression of miR-106b in colonic cancer.
Wang YX; Lang F; Liu YX; Yang CQ; Gao HJ
Int J Clin Exp Pathol; 2015; 8(1):786-92. PubMed ID: 25755775
[TBL] [Abstract][Full Text] [Related]
13. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma.
Tang J; Zhao H; Cai H; Wu H
Biomed Pharmacother; 2015 Apr; 71():222-6. PubMed ID: 25960240
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
Wang S; Li H; Wang J; Wang D; Yao A; Li Q
Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
[TBL] [Abstract][Full Text] [Related]
16. Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression.
Sun Q; Gu H; Zeng Y; Xia Y; Wang Y; Jing Y; Yang L; Wang B
Cancer Sci; 2010 Oct; 101(10):2241-7. PubMed ID: 20666778
[TBL] [Abstract][Full Text] [Related]
17. Low expression of miR-597 is correlated with tumor stage and poor outcome in breast cancer.
Zhang XY; Liu DJ; Yuan RB; Zhang DH; Li SR; Zhang SH; Zhang LY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):456-460. PubMed ID: 29424903
[TBL] [Abstract][Full Text] [Related]
18. Low expression of miR-409-3p is a prognostic marker for breast cancer.
Cao GH; Sun XL; Wu F; Chen WF; Li JQ; Hu WC
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3825-3829. PubMed ID: 27735035
[TBL] [Abstract][Full Text] [Related]
19. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
Liu X; Jutooru I; Lei P; Kim K; Lee SO; Brents LK; Prather PL; Safe S
Mol Cancer Ther; 2012 Jul; 11(7):1421-31. PubMed ID: 22553354
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and prognostic relevance of miR-1256 in colorectal cancer: a preliminary clinical study.
Liu ZY; Yang L; Chang HY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7704-7709. PubMed ID: 30536313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
